Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Designs Application Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Designs Cheryl J. Morris February 2, 2021 PALO ALTO, Calif., Jan. 7, 2021 /PRNewswire/ — Eiger BioPharmaceuticals, Inc (Nasdaq:EIGR), a industrial-stage biopharmaceutical firm targeted on... Read More Read more about Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Designs
